contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment CompanyTagList on Company {
  pageUrl
  name
  viewerIsFollowing
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    ...CompanyTagList
    id
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  availableLanguages
  pageUrl
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      defaultInstrument {
        isin
        id
      }
      id
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    id
    name
    viewerIsFollowing
    defaultInstrument {
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


invitation-to-audiocast-for-devysers-q3-report-2024

__typename

title

isPremium

lang

htmlBody

companies

createdAt

publishers

authors

reactionGroups

availableLanguages

pageUrl

imgUrl

description

Devyser Diagnostics develops, manufactures, and sells genetic tests to laboratories globally. The products are used for DNA tests in oncology, transplantation, and hereditary diseases to enable tailored cancer treatment, diagnosis of a large number of genetic diseases, and follow-up of transplant patients. The company is headquartered in Hägersten.

Devyser Diagnostics

On Wednesday, October 30 at 09:00 a.m. CET, Devyser Diagnostics AB will host an online presentation of its Q3 2024 report (which will have been published earlier on October 30 at 07:30 a.m. ...

<div class="mfn-preamble"><p><strong>On Wednesday, October 30 at 09:00 a.m. CET, Devyser Diagnostics AB will host an online presentation of its Q3 2024 report (which will have been published earlier on October 30 at 07:30 a.m. CET). The presentation will be held in English.</strong></p></div><div class="mfn-body"><p>If you wish to participate via&nbsp;webcast&nbsp;please use the link below. Via the&nbsp;webcast&nbsp;you&nbsp;are able to&nbsp;ask written questions. <a rel="noopener" href="https://ir.financialhearings.com/devyser-diagnostics-q3-report-2024/register">https://ir.financialhearings.com/devyser-diagnostics-q3-report-2024/register</a><br><br>If&nbsp;you&nbsp;wish&nbsp;to&nbsp;participate&nbsp;via&nbsp;teleconference&nbsp;please&nbsp;register on the&nbsp;link below.&nbsp;After registration you will be provided phone numbers and a conference ID to access the conference. You can ask questions verbally via the teleconference. <a rel="noopener" href="https://conference.financialhearings.com/teleconference/?id=50049152">https://conference.financialhearings.com/teleconference/?id=50049152</a>&nbsp;&nbsp;<br><br>Speakers: CEO Fredrik Alpsten&nbsp;and CCO Theis Kipling</p></div><div class="mfn-footer mfn-3ab42c8715f9"><p><strong class="mfn-heading-1">For more information, please contact:</strong><br>Fredrik Alpsten, CEO&nbsp;<br>E-mail: <a rel="noopener" href="mailto:fredrik.alpsten@devyser.com">fredrik.alpsten@devyser.com</a>&nbsp;&nbsp;<br>Telephone: +46 70 667 31 06  &nbsp;</p></div><div class="mfn-footer mfn-about mfn-89538f97f28b"><p><strong class="mfn-heading-1">About Devyser</strong><br>Devyser develops, manufactures and sells diagnostic solutions and analysis services to clinical laboratories in more than 65 countries. Our products are used for advanced genetic testing in the hereditary disease, oncology and transplant fields, to enable targeted cancer treatment, the diagnosis of a large number of genetic diseases, and transplant patient follow-up. Devyser's products, and unique, patented solution requiring only one test tube, simplify genetic testing processes, improve sample throughput, minimize hands-on time and deliver rapid results. Our goal is for every patient to receive a correct diagnosis in the shortest possible time. Sustainability is a central part of our business and an important prerequisite for long term value creation.</p><p>Devyser was founded in 2004 and is based in Stockholm, Sweden with eight in-house sales offices in Europe and the US. The company also runs Devyser Genomic Laboratories, a CLIA certified laboratory in Atlanta, US. In 2022, Devyser's quality management system was certified according to the IVDR and a number of the company's products have since been certified according to the IVDR.</p><p>Devyser's shares are listed on the Nasdaq First North Premier Growth Market Stockholm (ticker: DVYSR). The company's Certified Adviser is Redeye AB.&nbsp;</p><p>For more information, visit&nbsp;<a rel="noopener" href="http://www.devyser.com/">www.devyser.com</a>.&nbsp;</p></div><div class="mfn-footer mfn-attachment mfn-attachment-general"><p><strong class="mfn-heading-1">Attachments</strong><br><a rel="noopener" href="https://storage.mfn.se/bbf10801-e517-47fd-942a-bc67f06fbc9d/invitation-to-audiocast-for-devysers-q3-report-2024.pdf" class="mfn-generated mfn-primary">Invitation to audiocast for Devyser’s Q3 report 2024</a></p></div>

Pysy ajantasalla Inderesin uutiskirjeillä